Vanguard Group
ROIV icon

Vanguard Group’s Roivant Sciences ROIV Stock Holding History

Vanguard Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$913M Buy
42,059,041
+3,254,113
+8% +$64.2M 0.01% 749
2025
Q3 		$587M Sell
38,804,928
-521,408
-1% -$6.45M 0.01% 967
2025
Q2 		$443M Sell
39,326,336
-1,441,254
-4% -$15.6M 0.01% 1101
2025
Q1 		$411M Sell
40,767,590
-3,319,697
-8% -$35.9M 0.01% 1097
2024
Q4 		$522M Buy
44,087,287
+2,404,232
+6% +$28.4M 0.01% 1017
2024
Q3 		$481M Buy
41,683,055
+33,491,231
+409% +$381M 0.01% 1066
2024
Q2 		$86.6M Buy
8,191,824
+85,492
+1% +$937K ﹤0.01% 1902
2024
Q1 		$85.4M Buy
8,106,332
+1,030,681
+15% +$11.1M ﹤0.01% 1946
2023
Q4 		$79.5M Buy
7,075,651
+1,473,085
+26% +$14.4M ﹤0.01% 1979
2023
Q3 		$65.4M Buy
5,602,566
+3,440,374
+159% +$38.9M ﹤0.01% 2008
2023
Q2 		$21.8M Buy
2,162,192
+393,350
+22% +$3.52M ﹤0.01% 2553
2023
Q1 		$13.1M Buy
1,768,842
+119,943
+7% +$988K ﹤0.01% 2794
2022
Q4 		$13.2M Buy
1,648,899
+75,324
+5% +$419K ﹤0.01% 2827
2022
Q3 		$5.07M Buy
1,573,575
+57,226
+4% +$222K ﹤0.01% 3320
2022
Q2 		$6.17M Buy
1,516,349
+196,850
+15% +$781K ﹤0.01% 3259
2022
Q1 		$6.52M Buy
1,319,499
+159,787
+14% +$1.05M ﹤0.01% 3385
2021
Q4 		$11.7M Buy
+1,159,712
New +$9.65M ﹤0.01% 3130

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Vanguard Group's ROIV Position: Q4 2025 in Review

Vanguard Group increased its Roivant Sciences (ROIV) stake by 8.4% in Q4 2025, buying an estimated $64.2M and bringing the position to 42,059,041 shares worth $913M. The position accounts for 0.01% of the portfolio, ranked #749.

Vanguard Group first reported a position in ROIV in Q4 2021 and has held it in 17 quarters since. 396 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Vanguard Group held 42,059,041 shares of Roivant Sciences worth $913M as of Q4 2025.
  • Vanguard Group bought 3,254,113 Roivant Sciences shares in Q4 2025, an estimated $64.2M.
  • Roivant Sciences made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #749 holding.
  • Vanguard Group first reported a position in Roivant Sciences in Q4 2021 and has held it in 17 quarters since.
  • 396 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.